Concerning Atnx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Message :
Required fields
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Athenex, Inc. (“Athenex” or the “Company”) (NASDAQ: ATNX) investors concerning the Company’s possible violations of the federal securities laws.
If you suffered a loss on your Athenex investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/athenex-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights. ....

Bloomberg Businessweek , Charlesh Linehan , Glancy Prongay Murray , Drug Administration , Associated Press , Athenex Inc , Whistleblower Program , Securities Class Action Services , Glancy Prongay , New Drug Application , Complete Response Letter , Oral Paclitaxel , Class Action Services , Wall Street Journal , Financial Times , Business Daily , Attorney Advertising , Inc Stock Exchange , Press Release , Concerning Atnx , தொடர்புடையது ப்ரெஸ் , விசில்ப்ளோவர் ப்ரோக்ர்யாம் , பத்திரங்கள் வர்க்கம் நடவடிக்கை சேவைகள் , புதியது மருந்து விண்ணப்பம் , முழுமை பதில் கடிதம் , வர்க்கம் நடவடிக்கை சேவைகள் ,